Previous Meetings

GBCC 2023

Global Breast Cancer Conference 2023

08:30-09:15
Satellite Symposium 2
Pfizer Korea
Venue: RM 1(Vista 1+2)
  • Palbociclib: Added Value of Long-term Efficacy, Safety and Real-world Data
    Kyung-Hun Lee (Seoul National Univ. Hospital, Korea)
09:30-10:15
Plenary Lecture 3
Venue: RM 1(Vista 1+2)
  • Genomic Biology of Triple Negative Breast Cancer
    Edison Liu (The Jackson Laboratory, U.S.A.)
10:30-11:45
Education Session 4
Update of HER2+ Breast Cancer Treatment
Venue: RM 3(Walker Hall 1)
  • Systemic Treatment for HER2-positive Early Breast Cancer
    Jee Hung Kim (Yonsei Univ. College of Medicine, Korea)
  • Systemic Treatment for HER2-positive Metastatic Breast Cancer
    Soo Chin Lee (National Univ. Cancer Institute, Singapore)
  • Overview and Management of Adverse Events of Anti-HER2 ADCs
    Makiko Ono (The Cancer Institute Hospital of JFCR, Japan)
Symposium 5
Single Cell Proteogenomic and Translational Research in Breast Cancer
Venue: RM 1(Vista 1+2)
  • Single Cell Genomics in Breast Cancer
    Amos Lee (Seoul National Univ., Korea)
  • Single Cell Proteomic Technology and Future
    Junho Park (CHA Univ. College of Medicine, Korea)
  • Single Cell Genomics of Circulating Tumor Cells in Breast Cancer
    Andi Cani (Univ. of Michigan, U.S.A.)
Panel Discussion 4
Treatment Dilemma in the Management of Breast Cancer
Venue: RM 2(Vista 3)
  • Clinical Staging in Breast Cancer Patients Undergoing Neoadjuvant Treatment
    Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
  • Can cT3/4 Breast Cancer be Safely Treated with Breast Conserving Surgery After Neoadjuvant Treatment?
    Mehra Golshan (Yale School of Medicine, U.S.A.)
  • Is Sentinel LN Biopsy Feasible in Clinical N2-3 Patients After Neoadjuvant Treatment?
    Jean-Francois Boileau (Jewish General Hospital, McGill Univ., Canada)
Oral Presentation 5
Venue: RM 4(Walker Hall 2)
Nursing Session 1 (Kor.)
The Managements for Cognitive Impairment Related to Breast Cancer
Venue: RM 5(Art Hall)
  • The Impact of Chemotherapy on Cognitive Impairments: Evidence and Implications
    Hee-Ju Kim (The Catholic Univ. of Korea, Korea)
  • The Cognitive Impairment in Breast Cancer Patients Undergoing Therapy
    Hyejin Cho (Ewha Womans Univ. Seoul Hospital, Korea)
  • Beneficial Effects of Exercise on Cancer-related Cognitive Impairment with Breast Cancer Patients
    Seung-Soo Baek (Sangmyung Univ., Korea)
12:00-12:45
Plenary Lecture 4
Venue: RM 1(Vista 1+2)
  • Breast-Cancer Related Lymphedema: Myths, Facts, Risk Factors and New Approach
    Alphonse Taghian (Massachusetts General Hospital, U.S.A.)
13:00-13:45
Satellite Symposium 3
Lilly Korea
Venue: RM 1(Vista 1+2)
  • Take Hope Further for HR+HER2-high-risk Early Breast Cancer Patients with Abemaciclib
    Nadia Harbeck (LMU Univ. Hospital, Germany)
14:00-14:45
Plenary Lecture 5
Venue: RM 1(Vista 1+2)
  • Escalation and De-escalation of Breast Cancer Treatment
    Michael Gnant (Medical Univ. of Vienna, Austria)
15:00-16:15
Symposium 6
The Role of Imaging in the Personalized Treatment
Venue: RM 1(Vista 1+2)
  • The Role of Imaging for the Management of DCIS
    Mami Iima (Kyoto Univ. Hospital, Japan)
  • The Role of DW-MRI in the Personalized Screening and Diagnosis
    Savannah Partridge (Univ. of Washington, U.S.A.)
  • Quantitative Imaging in Outcome Prediction of Breast Cancer
    Vivian Youngjean Park (Yonsei Univ. College of Medicine, Korea)
Panel Discussion 5
Locoregional Treatment for Advanced/Recurrent Breast Cancer
Venue: RM 2(Vista 3)
  • Surgical Extent After Neoadjuvant Chemotherapy
    Geok Hoon Lim (KK Women's and Children's Hospital, Singapore)
  • Role of Repeat Breast-conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence
    Andreas Karakatsanis (Uppsala Univ. Hospital, Sweden)
  • Radiation Therapy According to Residual Tumor Volume After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Sung-Ja Ahn (Chonnam National Univ. Medical School, Korea)
Education Session 5
Liquid Biopsy: New Era of Cancer Management
Venue: RM 3(Walker Hall 1)
  • Basic Technology of Liquid Biopsy
    Eunhae Cho (GC Genome, Korea)
  • Clinical Utility of Detection of Early Recurrence or Minimal Residual Disease Using Liquid Biopsy in Early Breast Cancer
    Kan Yonemori (National Cancer Center Hospital, Japan)
  • Current Advances of Liquid Biopsy in Tumor Burden Dynamics, Response Monitoring and Prognostic Marker in Metastatic Breast Cancer
    Jisun Kim (ASAN Medical Center, Korea)
Nursing Session 2 (Kor.)
Living and Care as Women with Hereditary Breast Cancer
Venue: RM 5(Art Hall)
  • An Overview of Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome
    Bom-Yi Lee (Daerim St. Mary's Hospital, Korea)
  • Genetic Counseling for Hereditary Breast Cancer Patients
    Ji Hye Yang (ASAN Medical Center, Korea)
  • The Process of Choosing Cancer Risk-reducing Options in Women with Hereditary Breast Cancer: A Grounded Theory Study
    Sun-Young Park (Daegu Catholic Univ., Korea)
15:00-16:40
Endoscopic and Robotic Breast Surgery Session
Venue: RM 4(Walker Hall 2)
  • Challenges of Robot Breast Surgery: Is there a Role for Robot Breast Surgery Outside of Clinical Trial?
    Moo Hyun Lee (Keimyung Univ. School of Medicine, Korea)
  • Challenges of Endoscopic Breast Surgery: Is It Just a Bridge for Robot Breast Surgery?
    Chi Wei Mok (Changi General Hospital, Singhealth Duke NUS Breast Centre, Singapore)
  • Current Status of Robot Breast Surgery
    Wen-Ling Kuo (Chang Gung Memorial Hospital, Taiwan)
  • Robot Surgery for Breast Reconstruction
    Jesse Selber (Corewell Health, U.S.A.)
16:30-17:45
Symposium 7
PMRT/RNI in the Modern Era
Venue: RM 1(Vista 1+2)
  • Personalization of PMRT in the Modern Era
    Meena S. Moran (Yale School of Medicine, U.S.A.)
  • The Benefit of PMRT for Low Nodal Burden Breast Cancer in the Modern Treatment Era
    Kyung Hwan Shin (Seoul National Univ. Hospital, Korea)
  • Incorporation of New Systemic Agents in Patients Treated with PMRT
    Alice Ho (Duke Univ., U.S.A.)
Debate Session
Venue: RM 2(Vista 3)
  • Role of Platinum Agent in Early Triple Negative Breast Cancer - Pros.
    Jieun Lee (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
  • Role of Platinum Agent in Early Triple Negative Breast Cancer - Cons.
    Min Hwan Kim (Yonsei Univ. College of Medicine, Korea)
  • Genomic Risk vs. Clinical Risk in Early-stage, HR+ Breast Cancer - Genomic risk
    Dae-Won Lee (Seoul National Univ. Hospital, Korea)
  • Genomic Risk vs. Clinical Risk in Early-stage, HR+ Breast Cancer - Clinical risk
    Tae-Kyung Robyn Yoo (ASAN Medical Center, Korea)
Education Session 6
Post-operative Management and Surveillance Strategies for Breast Cancer Patients
Venue: RM 3(Walker Hall 1)
  • Surveillance Strategy Overview in Korea
    Hyeong-Gon Moon (Seoul National Univ. Hospital, Korea)
  • Post-operative Surveillance and Management for Breast Cancer Patients in Taiwan
    An-Chieh Feng (Tri-Service General Hospital, Taiwan)
  • The State-of-the-art Risk Prediction Tools and How They Apply to Asian Breast Cancer Screening Programs
    Jingmei Li (Genome Institute of Singapore, Singapore)
16:30-18:00
ABCN Business Meeting & Networking
Venue: RM 5(Art Hall)
  • Opening Remarks & Introduction: Mentoring for Mentors
    Sung-Bae Kim (ASAN Medical Center, Korea)
  • Keynote Lecture
    Sibylle Loibl (GBG Forschungs GmbH, Germany)
  • [Part 1] Expert Panel Discussion: Navigating Challenges and Building Synergies in Breast Cancer Research: Insights from Experienced Experts
    Hee Kyung Ahn (Gachon Univ. Gil Medical Center, Korea)
  • Topic 1: The Art of Mentorship: Nurturing a Successful Career and Strategies for Effective Collaboration
    Kyung-Hun Lee (Seoul National Univ. Hospital, Korea)
  • Topic 2: Beyond Borders: Leveraging International Networks and Overcoming Practical Obstacles
    Yoo Seok Kim (Chosun Univ. Hospital, Korea)
  • [Part 2] Introduction
    Sung-Bae Kim (ASAN Medical Center, Korea)
  • Proposal: Neoadjuvant Chemotherapy or Upfront Surgery in Clinically Node-positive, ER+HER2- Breast Cancer: A Multi-national Survey Study
    Sung Gwe Ahn (Gangnam Severance Hospital, Korea)
  • Product: Knowledge, Attitudes, and Behaviors toward Fertility Preservation in Patients with Breast Cancer: A Cross-Sectional Survey of Physicians
    Hee Jeong Kim (ASAN Medical Center, Korea)
16:50-17:50
OPBS Session
Venue: RM 4(Walker Hall 2)
  • Oncoplastic Breast Surgery: Where are We?
    Ho Yong Park (Kyungpook National Univ. Chilgok Hospital, Korea)
  • Advanced Surgical Technic for Successful OPBS in Breast Cancer
    Visnu Lohsiriwat (Siriraj Hospital, Mahidol Univ., Thailand)
  • Evaluation of Breast Symmetry and Cosmesis for Dense Breast
    Jung Ho Lee (The Catholic Univ. of Korea Bucheon St. Mary's Hospital, Korea)
18:00-18:45
Satellite Symposium 4
Novartis
Venue: RM 1(Vista 1+2)
  • Optimal and Sequential Treatment Strategy for HR+ HER2- aBC Patients for Longer and Better Life
    Keun Seok Lee (National Cancer Center, Korea)
Back to Previous Meetings